Emre Demirci

Istanbul, Turkey

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

Almost Complete Response with a Single Administration 225Ac-DOTATATE in a Patient with a Metastatic Neuroendocrine Tumor of Unknown Primary.

Almost Complete Response with a Single Administration 225Ac-DOTATATE in a Patient with a Metastatic Neuroendocrine Tumor of Unknown Primary.

Journal: Molecular imaging and radionuclide therapy

Published: June 30, 2022

Comparison of 68Ga-PSMA PET/CT and mp-MRI in regard to local staging for prostate cancer with histopathological results: A retrospective study.

Comparison of 68Ga-PSMA PET/CT and mp-MRI in regard to local staging for prostate cancer with histopathological results: A retrospective study.

Journal: The Prostate

Published: February 10, 2022

Imaging Cancer-Associated Fibroblasts (CAFs) with FAPi PET.

Imaging Cancer-Associated Fibroblasts (CAFs) with FAPi PET.

Journal: Biomedicines

Published: January 26, 2022

The Role of 68GA-PSMA PET/CT Scan In Patients with Prostate Adenocarcinoma who Underwent Radical Prostatectomy.

The Role of 68GA-PSMA PET/CT Scan In Patients with Prostate Adenocarcinoma who Underwent Radical Prostatectomy.

Journal: Urology journal

Published: December 22, 2020

[68Ga]DOTA-FAPI-04 PET/CT imaging in a case of a signet ring cell carcinoma of stomach.

[68Ga]DOTA-FAPI-04 PET/CT imaging in a case of a signet ring cell carcinoma of stomach.

Journal: European journal of nuclear medicine and molecular imaging

Published: November 18, 2020

Interobserver and intraobserver agreement on prostate-specific membrane antigen PET/CT images according to the miTNM and PSMA-RADS criteria.

Interobserver and intraobserver agreement on prostate-specific membrane antigen PET/CT images according to the miTNM and PSMA-RADS criteria.

Journal: Nuclear medicine communications

Published: May 27, 2020

Myelodysplastic Syndrome Presenting With Diffuse Bone Marrow Uptake on 68Ga-PSMA PET/CT.

Myelodysplastic Syndrome Presenting With Diffuse Bone Marrow Uptake on 68Ga-PSMA PET/CT.

Journal: Clinical nuclear medicine

Published: February 29, 2020

Post-therapy imaging of 225Ac-DOTATATE treatment in a patient with recurrent neuroendocrine tumor.

Post-therapy imaging of 225Ac-DOTATATE treatment in a patient with recurrent neuroendocrine tumor.

Journal: European journal of nuclear medicine and molecular imaging

Published: December 17, 2019

Clinical Impact of Lower-Limb Imaging in 68Ga-PSMA PET/CT for Patients with Prostate Cancer.

Clinical Impact of Lower-Limb Imaging in 68Ga-PSMA PET/CT for Patients with Prostate Cancer.

Journal: Journal of nuclear medicine technology

Published: December 02, 2018

Can SUVmax values of Ga-68-PSMA PET/CT scan predict the clinically significant prostate cancer?

Can SUVmax values of Ga-68-PSMA PET/CT scan predict the clinically significant prostate cancer?

Journal: Nuclear medicine communications

Published: November 06, 2018

177Lu-DOTATATE therapy in patients with neuroendocrine tumours including high-grade (WHO G3) neuroendocrine tumours: response to treatment and long-term survival update.

177Lu-DOTATATE therapy in patients with neuroendocrine tumours including high-grade (WHO G3) neuroendocrine tumours: response to treatment and long-term survival update.

Journal: Nuclear medicine communications

Published: June 19, 2018

ESTIMATION OF THE ORGAN ABSORBED DOSES AND EFFECTIVE DOSE FROM 68Ga-PSMA-11 PET SCAN.

ESTIMATION OF THE ORGAN ABSORBED DOSES AND EFFECTIVE DOSE FROM 68Ga-PSMA-11 PET SCAN.

Journal: Radiation protection dosimetry

Published: February 19, 2018

Showing 1-12 of 26

Last Updated: 09/26/2026